Financial Analysis

Procter & Gamble demonstrates a high-quality, investment-grade credit profile characterized by stable revenue generation, expanding margins, conservative leverage (~1.8x Net Debt/EBITDA), and robust free cash flow coverage of debt obligations across the FY2023–FY2025 review period.

Income Statement Analysis

Revenue growth decelerating but stable: Total revenues grew +2.5% YoY in FY2024 ($84.0B) and moderated to +0.3% in FY2025 ($84.3B), reflecting a mature, near-saturation top-line profile consistent with a large-cap consumer staples issuer.
- Three-year revenue base remains anchored above $82B, providing a predictable earnings floor.
- Low single-digit growth reflects pricing normalization following post-pandemic volume recovery rather than structural demand deterioration.
Gross margin expansion is material and sustained: Gross margin improved from 47.9% (FY2023) to 51.4% (FY2024) and held at 51.2% (FY2025), a ~330bps structural improvement.
- Expansion driven by favorable input cost trends and pricing carryover; FY2025 stability confirms margin durability rather than one-time benefit.
EBITDA margin inflected sharply in FY2025: EBITDA margin expanded from 19.6% (FY2024) to 22.4% (FY2025), with absolute EBITDA increasing to $18.9B (+$2.4B YoY).
- FY2023–FY2024 EBITDA was essentially flat ($16.4B vs. $16.5B); FY2025 step-up suggests operating leverage realization or below-the-gross-profit cost discipline.
- Operating margin similarly expanded to 24.3% in FY2025 vs. ~22.1% in FY2023–FY2024.
Net income trajectory is positive: Net income grew from $14.5B (FY2023) to $16.3B (FY2025), with net margin expanding from 17.7% to 19.4%, reflecting both operational improvement and stable below-the-line items.

Balance Sheet Analysis

Leverage is low and improving: Total Debt/EBITDA declined from 1.97x (FY2024) to 1.82x (FY2025), well within investment-grade thresholds; debt increase of ~$2.0B was more than offset by EBITDA growth.
- Total debt increased modestly from $32.5B to $34.5B, consistent with routine refinancing or working capital facility utilization.
Capital structure is conservatively positioned: Debt/Capital ratio of ~39.8% (FY2025) and Debt/Assets of ~27.6% reflect a balance sheet with significant equity cushion ($52.3B equity base).
- Debt/Equity of 0.66x is modest for a company of P&G's scale and cash generation capacity.
Asset base is growing: Total assets increased from $122.4B (FY2024) to $125.2B (FY2025), driven in part by PP&E growth ($22.2B to $23.9B), consistent with ongoing capital investment.
- Equity grew from $50.6B to $52.3B, indicating retained earnings accretion net of shareholder returns.
No operating lease adjustment required: Operating lease-adjusted debt equals reported debt in both periods, indicating minimal off-balance-sheet lease exposure relative to total obligations.

Cash Flow Analysis

CFO is strong but showed FY2025 normalization: Operating cash flow declined from $19.8B (FY2024) to $17.8B (FY2025), following an elevated FY2024 that likely benefited from working capital timing; FY2025 CFO remains well above FY2023 ($16.8B).
- CFO/Total Debt of 0.52x in FY2025 (vs. 0.61x in FY2024) remains strong in absolute terms.
CapEx is rising but manageable: Capital expenditures increased from $3.1B (FY2023) to $3.8B (FY2025), representing ~4.5% of revenue — consistent with maintenance and modest capacity investment for a consumer goods platform.
- CapEx/CFO ratio of ~21% in FY2025 leaves substantial residual cash flow for debt service and distributions.
FCF generation is robust: FCF of $14.0B in FY2025 (vs. $16.5B in FY2024) reflects the CFO normalization; FCF/Total Debt of 0.41x provides meaningful debt repayment capacity.
- Three-year average FCF of ~$14.8B underscores the consistency of cash generation across the cycle.
FFO improved materially in FY2025: FFO increased to $13.5B in FY2025 from $11.2B in FY2024, driven by EBITDA expansion; FFO/Total Debt of 0.39x is consistent with a low-investment-grade to high-yield boundary — well above P&G's actual credit profile.
- Financing outflows of ~$14.0B in FY2025 reflect ongoing shareholder returns (dividends + buybacks), a structural use of cash for this issuer.

Working Capital Analysis

Negative CCC is a structural credit positive: P&G operates with a deeply negative cash conversion cycle of approximately -57 days (FY2024) and -56 days (FY2025), meaning the business self-funds through supplier financing.
- DPO of ~113 days in both periods reflects P&G's dominant purchasing leverage over suppliers — a durable structural advantage.
Receivables and inventory turns are efficient: DSO of ~26 days and DIO of ~30–31 days are consistent with a consumer staples business selling through large retail channels with short collection cycles.
- DIO increased marginally (+1.1 days YoY) in FY2025, not material at current scale.
Working Capital Requirement (WCR) is structurally negative: WCR of -$12.8B (FY2025) confirms that P&G collects cash before paying suppliers — a net source of liquidity rather than a use.
- Negative WC of -$10.7B (FY2025) is not a liquidity concern given the business model; it reflects the payables-funded operating cycle.

Liquidity Analysis

Headline liquidity ratios are below 1.0x but not a concern: Current ratio of 0.70x and quick ratio of 0.49x in FY2025 reflect the structural negative working capital model; these ratios are expected and appropriate for P&G's business profile.
- Comparison to peers in consumer staples confirms sub-1.0x current ratios are sector-normal for companies with dominant payables leverage.
Cash position is adequate: Cash & equivalents of $9.6B (FY2025) provide a meaningful near-term liquidity buffer against the $9.5B CPLTD balance — near 1:1 coverage on a spot basis.
- CPLTD increased from $7.2B (FY2024) to $9.5B (FY2025), representing the primary near-term refinancing risk; manageable given access to capital markets and $13.5B FFO.
Operating CF Ratio declined but remains adequate: CFO/Current Liabilities of 0.49x (FY2025) vs. 0.59x (FY2024) reflects both the CFO normalization and the increase in current liabilities; annual FFO of $13.5B provides ample coverage.
- Undrawn credit facility data is not available in the provided dataset; confirmed availability would further strengthen the liquidity assessment.
Interest coverage is strong: EBITDA/Interest Expense of ~20.9x (FY2025) and EBIT/IE of ~22.5x confirm minimal debt service burden relative to earnings generation.

Debt & Coverage Analysis

Interest coverage is very strong across all metrics: EBITDA/IE of 20.9x (FY2025) and EBIT/IE of 22.5x reflect a company where interest expense ($907M) is de minimis relative to operating earnings ($20.5B).
- Coverage ratios are directionally consistent across FY2023–FY2025, with no deterioration trend.
- Note: EBIT/IE and EBITDA/IE are presented as negative values in the source data, indicating interest expense is recorded as a negative figure; absolute coverage multiples are referenced here.
EBITDA/(IE + CPLTD) tightened in FY2025: This blended debt service coverage metric declined from 2.63x (FY2024) to 2.20x (FY2025), driven by the $2.3B increase in CPLTD.
- 2.20x remains a comfortable coverage level; the decline is a function of debt maturity scheduling rather than earnings deterioration.
Leverage trajectory is improving: Net Debt/EBITDA declined from 1.97x (FY2024) to 1.82x (FY2025), consistent with EBITDA growth outpacing incremental debt issuance.
- At current FCF generation rates, P&G could theoretically retire all outstanding debt within approximately 2.5 years — a theoretical measure of balance sheet strength.
Financing outflows reflect shareholder return priority: CF Financing of -$14.0B (FY2025) indicates that substantially all FCF is returned to shareholders via dividends and buybacks, consistent with P&G's capital allocation policy; this is a structural feature, not a credit risk at current leverage levels.

CapEx Analysis

PP&E base is growing steadily: Net PP&E increased from $22.2B (FY2024) to $23.9B (FY2025), a $1.7B net increase, consistent with reported CapEx of $3.8B less estimated depreciation.
- Implied depreciation of approximately $2.0–$2.1B (derived from PP&E roll) is consistent with a capital-light consumer goods manufacturing model.
CapEx intensity is moderate and rising: Reported CapEx increased from $3.1B (FY2023) to $3.8B (FY2025), a ~23% increase over two years, suggesting capacity investment or manufacturing modernization.
- CapEx as a percentage of revenue: ~3.7% (FY2023), ~4.0% (FY2024), ~4.5% (FY2025) — trending upward but well within FCF generation capacity.
CapEx Estimate (PP&E-derived) is not computable for FY2024: Beginning PP&E for FY2024 is not available in the dataset; the FY2025 estimate is derivable from the FY2024–FY2025 PP&E roll. Reported CapEx figures are used as the primary reference.

Data Notes & Limitations

FY2023 balance sheet data unavailable: Total Debt, Total Assets, Total Equity, and all derived leverage/liquidity ratios for FY2023 are not present in the dataset; trend analysis for balance sheet metrics is limited to FY2024–FY2025.
Undrawn credit facility not provided: Revolving credit facility availability is not included; total liquidity may be materially understated. P&G is known to maintain significant committed credit lines; confirmation from public filings is recommended.
CapEx Estimate (PP&E-derived) incomplete: Beginning PP&E for FY2024 and depreciation figures for both periods are absent; the PP&E-based CapEx estimate cannot be computed. Reported CapEx from the cash flow statement is used throughout.
Interest coverage sign convention: EBIT/IE and EBITDA/IE are presented as negative values in the source data, consistent with interest expense being recorded as a negative line item; all coverage multiples in this memo are expressed in absolute terms.
Operating lease adjustment is nil: EBITDA (Op. Lease Adj.) equals reported EBITDA in all periods, and Total Debt (incl. Op. Leases) equals reported Total Debt; either operating leases are immaterial or are already capitalized in the reported figures. Verification against footnote disclosures is recommended.
Fiscal year convention: P&G's fiscal year ends June 30; FY2025 refers to the year ended June 30, 2025. All figures sourced from publicly reported financial statements.